Back
Cassava Sciences Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Sell
46
SAVA
Cassava Sciences
Last Price:
20.61
Seasonality Move:
-5.87%
Sell
14
AMLX
Amylyx Pharmaceuticals
Last Price:
1.82
Seasonality Move:
101.62%
Sell
46
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $20.23. The Score for SAVA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $1.76. The Score for AMLX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $20.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $1.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing selling pressure, which indicates risk of future bearish movement.
SAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 41.27 | Sell |
Chaikin Money Flow: | -390552 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.37 - 23.49) | Sell |
Bollinger Bands (100): | (20.63 - 24.99) | Sell |
AMLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 25.39 | Sell |
Chaikin Money Flow: | -1523096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.79 - 2.27) | Sell |
Bollinger Bands (100): | (3.04 - 16.76) | Sell |
SAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.56 | Sell |
20-day SMA: | 21.3 | Sell |
50-day SMA: | 21.27 | Sell |
200-day SMA: | 21.33 | Sell |
8-day EMA: | 21.31 | Sell |
20-day EMA: | 21.51 | Sell |
50-day EMA: | 21.74 | Sell |
200-day EMA: | 22.55 | Sell |
AMLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.94 | Sell |
20-day SMA: | 1.92 | Sell |
50-day SMA: | 4.09 | Sell |
200-day SMA: | 13.92 | Sell |
8-day EMA: | 1.9 | Sell |
20-day EMA: | 2.17 | Sell |
50-day EMA: | 4.59 | Sell |
200-day EMA: | 12.93 | Sell |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $1.67 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.01 per share, an increase next quarter of $0.14 per share, a decrease this year of $2.48 per share, and an increase next year of $0.62 per share.
Cassava Sciences Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amylyx Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |